Publications by authors named "Rohan Rathod"

Claim this Profile
D
Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes.
Mukul R Jain, Suresh R Giri, Chitrang J Trivedi, Bibhuti B Bhoi, Akshyaya Chandan Rath, Rohan M Rathod

J Pharmacol Exp Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.
Suresh R Giri, Bibhuti Bhoi, Chitrang Trivedi, Akshyaya Rath, Rohan Rathod

BMC Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
Mukul R Jain, Suresh R Giri, Bibhuti Bhoi, Chitrang Trivedi, Akshyaya Rath, Rohan Rathod

Liver Int· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis